Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06125405 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of the Telitacicept in Pediatric Patients With Frequently Relapsing or Steroid Dependent Nephrotic Syndrome

Study acronym: STERN
StatusRecruiting
PhasePhase 3
Started2023-11-28
View on ClinicalTrials.gov ↗

Amendment history

2024-08-20
minor
Study Status v1
Start dateestimated 2023-11-24→confirmed 2023-11-28
2023-11-08
minor
Original filing
The main objective is to evaluate the effectiveness of telitacicept in pediatric patients with frequently relapsing or steroid dependent nephrotic syndrome within the 52-week follow-up.
Trial Details
NCT Number NCT06125405
Lead Sponsor The Children's Hospital of Zhejiang University School of Medicine
Conditions Nephrotic Syndrome in Children, Telitacicept
Enrollment 20 participants
Start Date 2023-11-28
Primary Completion 2026-10-24 (estimated)
Study Completion 2027-10-24 (estimated)
Updated on ClinicalTrials.gov 2024-08-21